These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10467272)

  • 1. N-acetylcysteine and clotrimazole inhibit sickle erythrocyte dehydration induced by 1-chloro-2,4-dinitrobenzene.
    Shartava A; Shah AK; Goodman SR
    Am J Hematol; 1999 Sep; 62(1):19-24. PubMed ID: 10467272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gardos channel is responsible for CDNB-induced dense sickle cell formation.
    Shartava A; McIntyre J; Shah AK; Goodman SR
    Am J Hematol; 2000 Jul; 64(3):184-9. PubMed ID: 10861814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.
    Muzyamba MC; Gibson JS
    J Physiol; 2003 Mar; 547(Pt 3):903-11. PubMed ID: 12576491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.
    Brugnara C; de Franceschi L; Alper SL
    J Clin Invest; 1993 Jul; 92(1):520-6. PubMed ID: 8326017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of K+ efflux and dehydration of sickle cells by [(dihydroindenyl)oxy]alkanoic acid: an inhibitor of the K+ Cl- cotransport system.
    Vitoux D; Olivieri O; Garay RP; Cragoe EJ; Galacteros F; Beuzard Y
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4273-6. PubMed ID: 2726772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
    J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K+ efflux in deoxygenated sickle cells in the presence or absence of DIOA, a specific inhibitor of the [K+, Cl-] cotransport system.
    Olivieri O; Vitoux D; Bachir D; Beuzard Y
    Br J Haematol; 1991 Jan; 77(1):117-20. PubMed ID: 1998586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive in vitro effects of anti-sickling drugs.
    Stuart J; Mojiminiyi FB; Stone PC; Culliford SJ; Ellory JC
    Br J Haematol; 1994 Apr; 86(4):820-3. PubMed ID: 7918079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):927-33. PubMed ID: 14663274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydration response of sickle cells to sickling-induced Ca(++) permeabilization.
    Lew VL; Etzion Z; Bookchin RM
    Blood; 2002 Apr; 99(7):2578-85. PubMed ID: 11895796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the Ca-dependent K channel and of the KCl co-transport in sickle cell dehydration during cyclic deoxygenation.
    Apovo M; Beuzard Y; Galacteros F; Bachir D; Giraud F
    Biochim Biophys Acta; 1994 Feb; 1225(3):255-8. PubMed ID: 8312370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse.
    De Franceschi L; Beuzard Y; Jouault H; Brugnara C
    Blood; 1996 Oct; 88(7):2738-44. PubMed ID: 8839870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.
    De Franceschi L; Saadane N; Trudel M; Alper SL; Brugnara C; Beuzard Y
    J Clin Invest; 1994 Apr; 93(4):1670-6. PubMed ID: 7512989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C
    Curr Opin Hematol; 1995 Mar; 2(2):132-8. PubMed ID: 9371983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential oxygen sensitivity of the K+-Cl- cotransporter in normal and sickle human red blood cells.
    Gibson JS; Speake PF; Ellory JC
    J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):225-34. PubMed ID: 9679176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L; Rouyer-Fessard P; Alper SL; Jouault H; Brugnara C; Beuzard Y
    Blood; 1996 Feb; 87(3):1188-95. PubMed ID: 8562946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion content and transport and the regulation of volume in sickle cells.
    Brugnara C; Bunn HF; Tosteson DC
    Ann N Y Acad Sci; 1989; 565():96-103. PubMed ID: 2672974
    [No Abstract]   [Full Text] [Related]  

  • 19. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
    Stocker JW; De Franceschi L; McNaughton-Smith GA; Corrocher R; Beuzard Y; Brugnara C
    Blood; 2003 Mar; 101(6):2412-8. PubMed ID: 12433690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bepridil protects sickle cells against the adverse rheological effects of cyclical deoxygenation.
    Johnston MN; Ellory JC; Stuart J
    Br J Haematol; 1989 Dec; 73(4):522-6. PubMed ID: 2611138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.